SCHEMBL4779912

SCHEMBL4779912

CCOC(=O)C(C)N1C(=O)CCC(N2C(=O)c3csc(N)c3C2=O)C1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 6/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MPI P34949 1/20 0.33
POLB P06746 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPK1 P28482 1/20 0.32
TP53 P04637 1/20 0.32
MDM2 Q00987 1/20 0.32
PRKCZ Q05513 4/20 0.32
PRKCI P41743 1/20 0.32
DDB1 Q16531 2/20 0.32
CRBN Q96SW2 2/20 0.32
NPC1 O15118 1/20 0.32
HSD17B10 Q99714 2/20 0.31
HPGD P15428 2/20 0.31
MAPT P10636 3/20 0.31
GAA P10253 2/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4777865 0.90 DDB1 (0.32) ALDH1A1DDB1CRBN
SCHEMBL4780071 0.82 PIN1 (0.41) L3MBTL1ALDH1A1MEN1KMT2AMPI
SCHEMBL6755162 0.76 DDB1 (0.31) DDB1CRBN
SCHEMBL4776701 0.76 DDB1 (0.38) ALDH1A1POLBMAPK1DDB1CRBN
SCHEMBL4773163 0.76 CRBN (0.36) ALDH1A1DDB1CRBN
SCHEMBL4780692 0.76 DDB1 (0.32) ALDH1A1DDB1CRBNMAPT
SCHEMBL4777868 0.74 DDB1 (0.36) SMN1; SMN2DDB1CRBN
SCHEMBL4775564 0.74 CYP19A1 (0.37) MEN1KMT2ASMN1; SMN2DDB1CRBN
SCHEMBL4780184 0.73 DDB1 (0.33) SMN1; SMN2DDB1CRBN
SCHEMBL4780107 0.72 HTT (0.34) L3MBTL1ALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524742-B2 Use of 5H-thioeno(3,4-c)pyrrole-4,6-dione derivatives as tumor necrosis factor inhibitor TIANJIN HEMAY BIO-TECH CO., LTD. (CN) 2013-09-03 US disclosed
US-20120220631-A1 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR TIANJIN HEMAY BIO-TECH CO., LTD. (CN) 2012-08-30 US disclosed
US-8183260-B2 small molecule, low toxicity, high efficiency, high economic value; 5-(2,6-dioxopiperidin-3-yl)-5H-thieno(3,4-c)pyrrole-4,6-dione: TIANJIN HEMAY BIO-TECH CO., LTD. (CN) 2012-05-22 US disclosed
EP-1964842-A1 5H-THIENO [3,4-c]PYRROLE-4, 6-DIONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR Tian Jin Hemay Bio-Tech Co., Ltd. (CN) 2008-09-03 EP disclosed
US-20080176900-A1 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AND THEIR USE AS TUMOR NECROSIS FACTOR INHIBITORS TIANJIN HEMAY BIO-TECH CO., LTD. (CN) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220631-A1 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR TNF, TPMT, TNFRSF1A L3MBTL1 2170/4885ALDH1A1 646/4885MEN1 3064/4885
US-20080176900-A1 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AND THEIR USE AS TUMOR NECROSIS FACTOR INHIBITORS TNF, TNFRSF1A, CD40 L3MBTL1 2569/4885ALDH1A1 1581/4885MEN1 3591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.